Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.
about
Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Correction: A Multicenter, Ope ...... h Diagnosed Atopic Dermatitis.
@en
Correction: A Multicenter, Ope ...... h Diagnosed Atopic Dermatitis.
@nl
type
label
Correction: A Multicenter, Ope ...... h Diagnosed Atopic Dermatitis.
@en
Correction: A Multicenter, Ope ...... h Diagnosed Atopic Dermatitis.
@nl
prefLabel
Correction: A Multicenter, Ope ...... h Diagnosed Atopic Dermatitis.
@en
Correction: A Multicenter, Ope ...... h Diagnosed Atopic Dermatitis.
@nl
P2093
P1433
P1476
Correction: A Multicenter, Ope ...... h Diagnosed Atopic Dermatitis.
@en
P2093
Alfred von Krempelhuber
Darja Schmidt
Dinh V Dinh
Dorothea von Bredow
Garth Virgin
Javier Gomez Vera
Maria Yadira Hurley
Nathaly Arndtz-Wiedemann
Paul Chaplin
Philip Young
P304
P356
10.1371/JOURNAL.PONE.0142802
P407
P577
2015-11-10T00:00:00Z